Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.47 |
| ▸ | FNTA | P49354 | 2/20 | 0.42 |
| ▸ | FNTB | P49356 | 2/20 | 0.42 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.38 |
| ▸ | NPY4R | P50391 | 7/20 | 0.37 |
| ▸ | NPY1R | P25929 | 4/20 | 0.37 |
| ▸ | NPY2R | P49146 | 4/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.36 |
| ▸ | OTC | P00480 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30121023 | 0.96 | NOD1 (0.47) | NOD1FNTAFNTBPGGT1BNPY4R | |
| SCHEMBL30140821 | 0.95 | NOD1 (0.50) | NOD1FNTAFNTBPGGT1BPTGS1 | |
| SCHEMBL29404748 | 0.93 | NOD1 (0.47) | NOD1FNTAFNTBPGGT1BPTGS1 | |
| SCHEMBL27632326 | 0.93 | NOD1 (0.51) | NOD1FNTAFNTBPGGT1BPTGS1 | |
| SCHEMBL27632323 | 0.93 | NOD1 (0.51) | NOD1FNTAFNTBPGGT1BPTGS1 | |
| SCHEMBL30563253 | 0.91 | NOD1 (0.43) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL32684785 | 0.90 | NOD1 (0.49) | NOD1FNTAFNTBPGGT1BPTGS1 | |
| SCHEMBL29630329 | 0.90 | NOD1 (0.49) | NOD1FNTAFNTBPGGT1BPTGS1 | |
| SCHEMBL18378107 | 0.89 | NOD1 (0.43) | NOD1FNTAFNTBPGGT1BNPY4R | |
| SCHEMBL18378106 | 0.89 | NOD1 (0.43) | NOD1FNTAFNTBPGGT1BNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12257323-B2 | Modified wound dressings | CONVATEC TECHNOLOGIES INC. (US) | 2025-03-25 | — | — | US | disclosed |
| US-20240123091-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES, INC. | 2024-04-18 | — | — | US | disclosed |
| US-11865192-B2 | Modified wound dressings | CONVATEC TECHNOLOGIES, INC. (US) | 2024-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240123091-A1 | MODIFIED WOUND DRESSINGS | MMP8, CD68, ELANE | NOD1 1747/4885FNTA 3718/4885FNTB 3588/4885 |
| US-11865192-B2 | Modified wound dressings | MMP8, CD68, ELANE | NOD1 1747/4885FNTA 3718/4885FNTB 3588/4885 |
| US-12257323-B2 | Modified wound dressings | MMP8, CD68, ELANE | NOD1 1747/4885FNTA 3718/4885FNTB 3588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.